APA

Dørum A., Møller P., Kamsteeg E. J., Scheffer H., Burton M., Heimdal K. R., Maehle L. O., Hovig E., Tropé C. G., van der Hout A. H., van der Meulen M. A., Buys C. H. & te Meerman G. J. (19980616). A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing. : European journal of cancer (Oxford, England : 1990).

Chicago

Dørum A, Møller P, Kamsteeg E J, Scheffer H, Burton M, Heimdal K R, Maehle L O, Hovig E, Tropé C G, van der Hout A H, van der Meulen M A, Buys C H and te Meerman G J. 19980616. A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing. : European journal of cancer (Oxford, England : 1990).

Harvard

Dørum A., Møller P., Kamsteeg E. J., Scheffer H., Burton M., Heimdal K. R., Maehle L. O., Hovig E., Tropé C. G., van der Hout A. H., van der Meulen M. A., Buys C. H. and te Meerman G. J. (19980616). A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing. : European journal of cancer (Oxford, England : 1990).

MLA

Dørum A, Møller P, Kamsteeg E J, Scheffer H, Burton M, Heimdal K R, Maehle L O, Hovig E, Tropé C G, van der Hout A H, van der Meulen M A, Buys C H and te Meerman G J. A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing. : European journal of cancer (Oxford, England : 1990). 19980616.